BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27989429)

  • 1. Duloxetine lessens joint pain in early-stage breast cancer.
    Tanday S
    Lancet Oncol; 2017 Jan; 18(1):e10. PubMed ID: 27989429
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.
    Henry NL; Unger JM; Schott AF; Fehrenbacher L; Flynn PJ; Prow DM; Sharer CW; Burton GV; Kuzma CS; Moseley A; Lew DL; Fisch MJ; Moinpour CM; Hershman DL; Wade JL
    J Clin Oncol; 2018 Feb; 36(4):326-332. PubMed ID: 29136387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Venlafaxine Withdrawal Successfully Treated With a Short Course of Duloxetine.
    Cutler N
    Prim Care Companion CNS Disord; 2017 Feb; 19(1):. PubMed ID: 28196312
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse Events and Perception of Benefit From Duloxetine for Treating Aromatase Inhibitor-Associated Arthralgias.
    Schnell PM; Lustberg MB; Henry NL
    JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33842832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A probable case of movement disorder (Tardive dyskinesia) due to duloxetine treatment.
    Yılmaz R; Üstün D; Tuncer Uzun S; Reisli R; Türk Ş
    Agri; 2018 Oct; 30(4):199-201. PubMed ID: 30403275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duloxetine and gingival bleeding: a case-report and reviews of the French and World PharmacoVigilance Databases and literature.
    Gicquel C; Moulis F; Chenaf C; Gouraud A; Drici M; Bondon-Guitton E; Montastruc F; Montastruc JL
    Eur J Clin Pharmacol; 2017 Sep; 73(9):1197-1198. PubMed ID: 28639120
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
    Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
    Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202.
    Henry NL; Unger JM; Till C; Schott AF; Crew KD; Lew DL; Fisch MJ; Moinpour CM; Wade JL; Hershman DL
    Cancer; 2019 Jun; 125(12):2123-2129. PubMed ID: 30861098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms.
    Henry NL; Unger JM; Till C; Crew KD; Fisch MJ; Hershman DL
    JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34901744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prurigo successfully treated with duloxetine hydrochloride.
    Hashimoto T; Satoh T; Yokozeki H
    Australas J Dermatol; 2019 Aug; 60(3):237-239. PubMed ID: 30675900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.
    Lassen D; Ennis ZN; Damkier P
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):32-6. PubMed ID: 26435496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is duloxetine an alternative in the treatment of osteoarthritis?
    Ananías J; Irarrázaval S
    Medwave; 2017 Oct; 17(8):e7063. PubMed ID: 29053665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsibility of the doctor who prescribes serotonin and noradrenaline reuptake inhibitors for patients with chronic musculoskeletal pain.
    Nagamine T
    Psychiatry Clin Neurosci; 2018 Jan; 72(1):45-46. PubMed ID: 29064131
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials.
    Wang ZY; Shi SY; Li SJ; Chen F; Chen H; Lin HZ; Lin JM
    Pain Med; 2015 Jul; 16(7):1373-85. PubMed ID: 26176791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine as an Analgesic Reduces Opioid Consumption After Spine Surgery: A Randomized, Double-Blind, Controlled Study.
    Bedin A; Caldart Bedin RA; Vieira JE; Ashmawi HA
    Clin J Pain; 2017 Oct; 33(10):865-869. PubMed ID: 28002096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled, double-blinded trial of duloxetine in the treatment of general fatigue in patients with chronic fatigue syndrome.
    Arnold LM; Blom TJ; Welge JA; Mariutto E; Heller A
    Psychosomatics; 2015; 56(3):242-53. PubMed ID: 25660434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
    Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
    J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sore Mouth.
    Chaubal TV; Bapat R
    Am J Med; 2021 Apr; 134(4):e270. PubMed ID: 32997980
    [No Abstract]   [Full Text] [Related]  

  • 19. Duloxetine Uses in Patients With Kidney Disease: Different Recommendations From the United States Versus Europe and Canada.
    Nguyen T; Shoukhardin I; Gouse A
    Am J Ther; 2019; 26(4):e516-e519. PubMed ID: 29419534
    [No Abstract]   [Full Text] [Related]  

  • 20. Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort study.
    Laroche F; Coste J; Medkour T; Cottu PH; Pierga JY; Lotz JP; Beerblock K; Tournigand C; Declèves X; de Cremoux P; Bouhassira D; Perrot S
    J Pain; 2014 Mar; 15(3):293-303. PubMed ID: 24365325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.